MedPath

JAMP-BEZAFIBRATE SR

JAMP-BEZAFIBRATE SR

Approved
DIN Number

02453312

Drug Class

Human

Market Date

Apr 6, 2016

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02453312
AIG Number0122820001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AB02 BEZAFIBRATE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification24:06.06
Health Canada Classification

ACTIVE INGREDIENTS (1)

BEZAFIBRATEActive
Strength: 400 MG
Monograph: BEZAFIBRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.